1. Home
  2. UPWK vs TYRA Comparison

UPWK vs TYRA Comparison

Compare UPWK & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upwork Inc.

UPWK

Upwork Inc.

HOLD

Current Price

$10.93

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$39.30

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPWK
TYRA
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
UPWK
TYRA
Price
$10.93
$39.30
Analyst Decision
Buy
Strong Buy
Analyst Count
12
9
Target Price
$22.73
$46.38
AVG Volume (30 Days)
2.9M
975.1K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$787,784,000.00
N/A
Revenue This Year
$9.10
N/A
Revenue Next Year
$13.60
N/A
P/E Ratio
$13.02
N/A
Revenue Growth
2.40
N/A
52 Week Low
$10.52
$6.42
52 Week High
$22.84
$40.65

Technical Indicators

Market Signals
Indicator
UPWK
TYRA
Relative Strength Index (RSI) 34.86 63.74
Support Level N/A $20.86
Resistance Level $13.97 N/A
Average True Range (ATR) 0.48 2.34
MACD 0.12 -0.01
Stochastic Oscillator 19.81 84.34

Price Performance

Historical Comparison
UPWK
TYRA

About UPWK Upwork Inc.

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: